Pricing Log in Create free account
Saturday 17 October 2026 Export PFE’s income statement to Excel — free account

Pfizer Inc.

PFE Healthcare Drug Manufacturers General

Pfizer Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.6 billion, down 1.65% from fiscal 2024. In the quarter to June 2026, revenue grew 2.60%, EPS fell 107.8%, free cash flow grew 125.2% and total debt rose 2.26%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years; insiders bought in the last twelve months.

29.58 0.14 +0.48%
Market cap
$167.8B
P/E
38.9×
Fwd P/E
12.2×
Dividend yield
5.81%
F-score
6/9
Altman Z
2.03
Beneish M
−2.52
Dividend safety
28/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Pfizer Inc. (PFE) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Pfizer Inc. (PFE) trades at a P/E ratio of 38.9×. Over the past ten years it has ranged from 0.0× (September 2024) to 82.6× (January 2024); the current reading is higher than 98% of that period. That is above the Drug Manufacturers General industry median of 24.5× and above the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 18.3× (2.11%)
FY2024 18.7× (77.35%)
FY2023 82.6× 797.36%
FY2022 9.2× (39.22%)
FY2021 15.1× (29.25%)
FY2020 21.4× 67.55%
FY2019 12.8× (42.01%)
FY2018 22.0× 127.47%
FY2017 9.7× (63.81%)
FY2016 26.8× 10.08%

Quarterly newest first

Period P/E ratio Change
Jun 2026 31.7× 47.81%
Mar 2026 21.4× 17.08%
Dec 2025 18.3× 23.59%
Sep 2025 14.8× 15.51%
42 more quarters

Against its own ten years

Low 0.0× High 82.6×
Ten-year median 18.3×
Current reading's percentile 97

P/E ratio against peers

Company P/E ratio
GILD Gilead Sciences, Inc. compare n/m
NVO Novo Nordisk A/S compare 9.5×
BMY Bristol Myers Squibb Company compare 13.2×
GSK GSK PLC Sponsored ADR compare 15.4×
SNY Sanofi compare 21.3×
NVS Novartis AG compare 22.6×
AZN AstraZeneca PLC compare 24.5×
AMGN Amgen Inc. compare 26.7×
PFE Pfizer Inc. 38.9×
Drug Manufacturers General industry median 24.5×
Healthcare sector median 23.0×
Market median 18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on PFE